Sarah Hochberg Luijpers PMP, CLSSBB

Sarah Luijpers’ varied background and experience in her 25+ years in the pharmaceutical industry has given her a broad perspective in which she shares with her colleagues daily. Prior to joining Allergan, Sarah spent ~20 years with Schering Plough (now Merck) starting off as a site monitor and progressing throughout the Clinical Development organization. Sarah also oversaw all Global Early Stage Development Operations at Schering Plough.
Sarah then transitioned to Forest where she has overseen various groups within Drug Development Operations from Recruitment and Vendor Management, to her current role as Head of DDO Business Operations overseeing, among others, Feasibility Analysis for Clinical Trials (FACT) and Systems and Reporting.